REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 91 filers reported holding REVOLUTION MEDICINES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,660,428 | +103376.7% | 4,684,264 | 0.0% | 6.90% | +18.8% |
| Q2 2023 | $125,304 | +23.5% | 4,684,264 | 0.0% | 5.81% | +16.6% |
| Q1 2023 | $101,461 | -99.9% | 4,684,264 | +17.6% | 4.98% | -0.4% |
| Q4 2022 | $94,905,168 | +20.8% | 3,984,264 | 0.0% | 5.00% | +13.2% |
| Q3 2022 | $78,570,000 | +15.7% | 3,984,264 | +14.4% | 4.42% | +2.7% |
| Q2 2022 | $67,908,000 | -23.6% | 3,484,264 | 0.0% | 4.30% | -5.8% |
| Q1 2022 | $88,884,000 | +1.4% | 3,484,264 | 0.0% | 4.57% | +34.1% |
| Q4 2021 | $87,699,000 | -8.5% | 3,484,264 | 0.0% | 3.41% | +1.8% |
| Q3 2021 | $95,852,000 | -13.3% | 3,484,264 | 0.0% | 3.35% | -14.2% |
| Q2 2021 | $110,591,000 | -30.8% | 3,484,264 | 0.0% | 3.90% | -28.0% |
| Q1 2021 | $159,858,000 | +22.0% | 3,484,264 | +5.3% | 5.42% | +28.7% |
| Q4 2020 | $131,014,000 | +13.8% | 3,309,264 | 0.0% | 4.21% | +5.8% |
| Q3 2020 | $115,162,000 | +23.3% | 3,309,264 | +11.8% | 3.98% | -3.1% |
| Q2 2020 | $93,424,000 | +39.8% | 2,959,264 | -3.0% | 4.11% | -9.8% |
| Q1 2020 | $66,820,000 | – | 3,049,764 | – | 4.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |